Cargando…
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
The polycomb repressor complex 2 molecule EZH2 is now known to play a role in essential cellular processes, namely, cell fate decisions, cell cycle regulation, senescence, cell differentiation, and cancer development/progression. EZH2 inhibitors have recently been developed; however, their effective...
Autores principales: | Li, Zhenghao, Takenobu, Hisanori, Setyawati, Amallia Nuggetsiana, Akita, Nobuhiro, Haruta, Masayuki, Satoh, Shunpei, Shinno, Yoshitaka, Chikaraishi, Koji, Mukae, Kyosuke, Akter, Jesmin, Sugino, Ryuichi P., Nakazawa, Atsuko, Nakagawara, Akira, Aburatani, Hiroyuki, Ohira, Miki, Kamijo, Takehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955864/ https://www.ncbi.nlm.nih.gov/pubmed/29507419 http://dx.doi.org/10.1038/s41388-018-0133-3 |
Ejemplares similares
-
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022) -
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021) -
CFC1 is a cancer stemness-regulating factor in neuroblastoma
por: Chikaraishi, Koji, et al.
Publicado: (2017) -
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023) -
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
por: Mukae, Kyosuke, et al.
Publicado: (2023)